LSP BioVentures

LSP BioVentures

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

United States, Cambridge


LSP BioVentures is a well known and established VC, which was founded in 2006. The primary office of this VC is located in Cambridge. This investor is located in North America, United States.

The usual method for the fund is to invest in rounds with 4-5 other investors. Aside from LSP BioVentures, start-ups are often funded by Life Sciences Partners, VI Partners AG, Prolog Ventures and 13 other funds. The most common co-investors for the fund are VI Partners AG, Seventure Partners, PMV and also 2 different VCs. In subsequent rounds, the fund is usually supported by Life Sciences Partners, Neomed Management, Ysios Capital.

The fund has a preferred number of founders for start-ups that it invests in. We can highlight the most popular investment areas for this fund, such as Therapeutics, Medical. In addition, there are 11 more industries where it has achieved success. Also, a start-up has to be aged 4-5 years to expect investment from this fund. The country of its foundation and the country of the most frequent investments for the fund coincides - United States. In addition to this location, the fund participated in 5 other locations. Lumeon, Nouscom, Rainier Therapeutics are among the most popular portfolio start-ups of the fund.

We also identified another 10 core personnel in our database.

The fund typically enters into less than 2 deals annually. We recorded the biggest number of exits for this fund in 2017. In real terms, this VC performs 44 percentage points more exits than other funds. LSP BioVentures is involved in 21 percentage points more than the average amount of lead investments when compared with other funds. The most common rounds for this fund are in the range of 10 - 50 millions dollars. The fund's activity peaked in 2017. Additionally, in 2019 the fund was active.

Year Founded


Fund Activity


Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name:; User name format in descending order of probability: first '.' last

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Investments per Year [average amount of rounds in which fund participates each year]


Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

6.7% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]


Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

0.9 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.1 out of 1

Funds Investing in Previous

Life Sciences Partners, VI Partners AG, Prolog Ventures

Funds Investing Together

VI Partners AG, Seventure Partners, PMV

Funds Investing in Following

Life Sciences Partners, Neomed Management, Ysios Capital

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: